USFDA approval Archives - Page 4 of 14

Zydus Lifesciences Shares Gain Marginally Over USFDA Approval for Diabetic Drug

Ali WaghbakriwalaOctober 23, 2023October 23, 2023

by Ali WaghbakriwalaOctober 23, 2023October 23, 202306811

Zydus Lifesciences shares were trading marginally above on 23 October after the company announced receiving approval from USFDA (the United States Food and Drug Administration)...

MARKETS

Aurobindo Pharma gets Approval from USFDA for its Icatibant Injection

Ali WaghbakriwalaAugust 16, 2023August 16, 2023

by Ali WaghbakriwalaAugust 16, 2023August 16, 202303415

Eugia Pharma Specialities, a wholly-owned subsidiary of Aurobindo Pharma, on 16 August received approval from the USFDA (United States Food and Drug Administration to manufacture...

MARKETS

Zydus Lifescience Gets Approval from USFDA on Arthritis Drug; Shares rally 4%

Ali WaghbakriwalaAugust 3, 2023August 3, 2023

by Ali WaghbakriwalaAugust 3, 2023August 3, 202309977

Zydus Lifesciences has received final approval from the USFDA (United States Food and Drug Administration) to manufacture and market its Arthritis drug Indomethacin suppositories 50mg....

BUSINESS

Lupin gets Approval from USFDA for Birth-Control Pills

Ali WaghbakriwalaAugust 1, 2023August 1, 2023

by Ali WaghbakriwalaAugust 1, 2023August 1, 2023015549

Lupin received approval from the US Food and Drug Administration for manufacturing and marketing Turqoz, a genetic equivalent of the pregnancy prevention pill Lo/Ovral-28. The...

BUSINESS

Aurobindo Pharma Arm Gets USFDA Approval for Plerixafor Injection

Ali WaghbakriwalaJuly 25, 2023July 25, 2023

by Ali WaghbakriwalaJuly 25, 2023July 25, 202301997

Eugia Pharma, a wholly-owned arm of Aurobindo Pharma Ltd, on July 25 Thursday said it had received final approval from the US Food and Drug...

MARKETS

Lupin Receives Approval from USFDA for Chlorpromazine Hydrochloride Tablets; Shares Gain on Approval

Ali WaghbakriwalaJuly 17, 2023July 17, 2023

by Ali WaghbakriwalaJuly 17, 2023July 17, 202302453

On July 14, Lupin announced that its subsidiary, Lupin Inc, which is based in Somerset, New Jersey, had received a nod from United States Food...

MARKETS

Marksans Pharma Share gained 9%, USFDA Nod to Pain Relief Tablets

Ali WaghbakriwalaJuly 12, 2023July 12, 2023

by Ali WaghbakriwalaJuly 12, 2023July 12, 202304441

Marksans Pharma Ltd announced on Wednesday that it had received approval from the US Food and Drug Administration department on its new Drug application for...

MARKETS

Shilpa Medicare Shares Soar 9% as USFDA Approves To Psoriatic Arthritis Drug

Chinmay BohraApril 11, 2023April 11, 2023

by Chinmay BohraApril 11, 2023April 11, 202301546

The Shilpa Medicare share price mounted 9% in the opening trade on Tuesday soon after the company acknowledged the final approval for its Apremilast tablets...

MARKETS

Morepen Labs Shares Zoom 18% over Clearing USFDA Inspection

Chinmay BohraMarch 27, 2023March 27, 2023

by Chinmay BohraMarch 27, 2023March 27, 202302555

On Monday, shares of Morepen Laboratories, a smallcap pharma company that manufactures Burnol, surged up to 18% during intra-day trades following an announcement to the...

Wockhardt Ltd Receives USFDA Approval For Cancer Treatment Drug

adminJanuary 21, 2019

by adminJanuary 21, 20190958

Wockhardt Ltd. announced that the drugmaker has received approval from the U.S. health regulator, USFDA, for the generic version of Gleevec used for the treatment...

Download Unicorn Signals App

EquityPandit

Tag : USFDA approval

Zydus Lifesciences Shares Gain Marginally Over USFDA Approval for Diabetic Drug

Aurobindo Pharma gets Approval from USFDA for its Icatibant Injection

Zydus Lifescience Gets Approval from USFDA on Arthritis Drug; Shares rally 4%

Lupin gets Approval from USFDA for Birth-Control Pills

Aurobindo Pharma Arm Gets USFDA Approval for Plerixafor Injection

Lupin Receives Approval from USFDA for Chlorpromazine Hydrochloride Tablets; Shares Gain on Approval

Marksans Pharma Share gained 9%, USFDA Nod to Pain Relief Tablets

Shilpa Medicare Shares Soar 9% as USFDA Approves To Psoriatic Arthritis Drug

Morepen Labs Shares Zoom 18% over Clearing USFDA Inspection

Wockhardt Ltd Receives USFDA Approval For Cancer Treatment Drug

EquityPandit